| PTEN loss but not ERG expression in diagnostic biopsies is associated with increased risk of progression and adverse surgical findings in men with prostate cancer on active … U Lokman, AM Erickson, H Vasarainen, AS Rannikko, T Mirtti European urology focus 4 (6), 867-873, 2018 | 45 | 2018 |
| Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ... Modern Pathology 29 (12), 1565-1574, 2016 | 43 | 2016 |
| New prostate cancer grade grouping system predicts survival after radical prostatectomy A Erickson, K Sandeman, K Lahdensuo, S Nordling, M Kallajoki, ... Human pathology 75, 159-166, 2018 | 21 | 2018 |
| Repeat multiparametric MRI in prostate cancer patients on active surveillance JT Eineluoto, P Järvinen, A Kenttämies, TP Kilpeläinen, H Vasarainen, ... PloS one 12 (12), e0189272, 2017 | 21 | 2017 |
| Fibroblast as a critical stromal cell type determining prognosis in prostate cancer S Blom, A Erickson, A Östman, A Rannikko, T Mirtti, O Kallioniemi, ... The Prostate 79 (13), 1505-1513, 2019 | 20 | 2019 |
| Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy JK Björk, I Ahonen, T Mirtti, A Erickson, A Rannikko, A Bützow, S Nordling, ... Oncotarget 9 (58), 31200, 2018 | 18 | 2018 |
| Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis K Lahdensuo, A Rannikko, VJ Anttila, A Erickson, A Pätäri-Sampo, ... Prostate cancer and prostatic diseases 19 (4), 417-422, 2016 | 15 | 2016 |
| Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors V Udhane, C Maranto, DT Hoang, L Gu, A Erickson, S Devi, PG Talati, ... Molecular Cancer Therapeutics 19 (1), 231-246, 2020 | 12 | 2020 |
| Positive STAT5 protein and locus amplification status predicts recurrence after radical prostatectomy to assist clinical precision management of prostate cancer BR Haddad, A Erickson, V Udhane, PS LaViolette, JD Rone, MA Kallajoki, ... Cancer Epidemiology and Prevention Biomarkers 28 (10), 1642-1651, 2019 | 10 | 2019 |
| A systematic review of prostate cancer heterogeneity: understanding the clonal ancestry of multifocal disease A Erickson, A Hayes, T Rajakumar, C Verill, RJ Bryant, FC Hamdy, ... European urology oncology, 2021 | 6 | 2021 |
| Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer K Sopyllo, AM Erickson, T Mirtti Cancers 13 (4), 628, 2021 | 4 | 2021 |
| Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study AM Erickson, S Luzzago, A Semjonow, H Vasarainen, TD Laajala, G Musi, ... European Urology Oncology 1 (4), 268-275, 2018 | 4 | 2018 |
| 274 Prostate cancer active surveillance: Health-related quality of life in the Finnish arm of the prospective PRIAS-study. Three year update U Lokman, H Vasarainen, K Lahdensuo, AM Erickson, K Taari, TK Mirtti, ... European Urology Supplements 12 (1), e274-e275, 2013 | 4 | 2013 |
| Transcript analysis of commercial prostate cancer risk stratification panels in hard‐to‐predict grade group 2–4 prostate cancers TPK Lehto, C Stürenberg, A Malén, AM Erickson, H Koistinen, IG Mills, ... The Prostate 81 (7), 368-376, 2021 | 3 | 2021 |
| Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy K Sandeman, JT Eineluoto, J Pohjonen, A Erickson, TP Kilpeläinen, ... Plos one 15 (7), e0235779, 2020 | 3 | 2020 |
| PP2A inhibitor PME-1 suppresses anoikis, and is associated with therapy relapse of PTEN-deficient prostate cancers C Rupp, A Aakula, A Isomursu, A Erickson, O Kauko, P Shah, A Padzik, ... bioRxiv, 581660, 2019 | 3 | 2019 |
| Ductal adenocarcinoma of the prostate: A systematic review and meta‐analysis of incidence, presentation, prognosis, and management N Ranasinha, A Omer, Y Philippou, E Harriss, L Davies, K Chow, ... BJUI Compass, 0 | 3 | |
| PTEN and ERG expression in MRI‐ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer AM Erickson, U Lokman, K Lahdensuo, S Tornberg, H Visapaa, ... The Prostate 80 (13), 1118-1127, 2020 | 2 | 2020 |
| The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line … V Udhane, C Maranto, D Hoang, A Erickson, S Devi, K Jacobsohn, ... Journal of Clinical Oncology 37 (7_suppl), 221-221, 2019 | 2 | 2019 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... | 1 | 2021 |
